SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases: which are the benefits?
Journal Title: Revista de Medicină Militară - Year 2019, Vol 0, Issue 1
Abstract
Two major trials, EMPA-REG OUTCOME trial (with Empagliflozin) and CANVAS trial (with Canagliflozin) have demonstrated the beneficial effects of SGLT2 inhibitors in patients with type 2 diabetes at risk for heart failure. SGLT2 inhibitors possess a unique pharmacological profile and have shown a significant reduction of hospitalization for heart failure in diabetic patients, immediately after treatment commencement. It seems that their effects are beneficial both in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. SGLT2 inhibitors reduce cardiovascular endpoints in patients with diabetes and high cardiovascular risk, most likely through a reduction of heart failure-related events. Empagliflozin treatment exerts beneficial effects on vascular function and central haemodynamics. Various mechanisms seem to contribute to the beneficial effects of SGLT2 inhibitors in heart failure. Taking into consideration their cardiovascular benefits and the number of ongoing trials with these drugs, there is a possibility to expand their indication to nondiabetic patients with heart failure. This review focuses on the newest insights into the beneficial effects of SGLT2 inhibitors on the cardiovascular system
Authors and Affiliations
Camelia Diaconu, Teodor Salmen, Mihnea A Gaman, Ovidiu Bratu, Dan Mischianu, D Marcu, Andra I Suceveanu, Raluca S. Costache, Anca Pantea Stoian
Keywords
Related Articles
- EP ID EP481269
- DOI -
- Views 94
- Downloads 0
Hepatic hydatid cysts
-
Diagnostic difficulties in c-kit negative gastrointestinal stromal tumors: report of 4 cases
Introduction: The gastrointestinal stromal tumors (GIST) are dominated by KIT and PDGFRA mutation. The immunohistochemical detection of CD117, a protein express by KIT gene, is essential for the diagnosis and those that...
Efficacy and tolerability of calcium channel alpha-2-delta ligands in psychiatric disorders
Matching drugs with anxiolytic properties- but without the potential of inducing dependence or abuse- with clinical manifestations of various affective disorders is a very important challenge for psychiatrists. Although...
Papillary thyroid carcinoma arising in a hypertrophic pyramidal lobe
-
Management of Helicobacter pylori infection – new insights
Introduction: Our objective is to review current international guidelines for Helicobacter Pylori treatment and our department`s experience in this field. Materials and methods: Helicobacter pylori is a Gram-negative, mi...